{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:19:46Z","timestamp":1793974786838,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The influence of sex on primary sclerosing cholangitis (PSC), pre- and postliver transplantation (LT) is unclear. Aims are to assess whether there have been changes in incidence, profile, and outcome in LT-PSC patients in Europe with specific emphasis on sex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Analysis of the European Liver Transplant Registry database (PSC patients registered before 2018), including baseline demographics, donor, biochemical, and clinical data at LT, immunosuppression, and outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>European Liver Transplant Registry analysis (n\u2009=\u20096463, 32% female individuals) demonstrated an increasing number by cohort (1980\u20131989, n\u2009=\u2009159; 1990\u20131999, n\u2009=\u20091282; 2000\u20132009, n\u2009=\u20092316; 2010\u20132017, n\u2009=\u20092549) representing on average 4% of all transplant indications. This increase was more pronounced in women (from 1.8% in the first cohort to 4.3% in the last cohort). Graft survival rate at 1, 5, 10, 15, 20, and 30 y was 83.6%, 70.8%, 57.7%, 44.9%, 30.8%, and 11.6%, respectively. Variables independently associated with worse survival were male sex, donor and recipient age, cholangiocarcinoma at LT, nondonation after brain death donor, and reduced size of the graft. These findings were confirmed using a more recent LT population closer to the current standard of care (LT after the y 2000).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>An increasing number of PSC patients, particularly women, are being transplanted in European countries with better graft outcomes in female recipients. Other variables impacting outcome include donor and recipient age, cholangiocarcinoma, nondonation after brain death donor, and reduced graft size.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003542","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T05:53:24Z","timestamp":1605851604000},"page":"2255-2262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry"],"prefix":"10.1097","volume":"105","author":[{"given":"Marina","family":"Berenguer","sequence":"first","affiliation":[{"name":"Hepatology and Liver Transplant Unit, La Fe University Hospital and Ciberehd, IISLaFe, Universidad de Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Di Maira","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Transplant Unit, La Fe University Hospital and Ciberehd, IISLaFe, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Baumann","sequence":"additional","affiliation":[{"name":"Hannover Medical School, Paediatric Gastroenterology and Hepatology, Hannover, Germany."},{"name":"University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius F.","family":"Mirza","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary and Liver Transplant Surgery, Queen Elizabeth University Hospitals Birmingham, NHS Foundation Trust, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King\u2019s College Hospital National Health Service Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen L.","family":"Klempnauer","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bennet","sequence":"additional","affiliation":[{"name":"Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Goran","family":"Ericzon","sequence":"additional","affiliation":[{"name":"Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l-Dag","family":"Line","sequence":"additional","affiliation":[{"name":"Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Lodge","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Unit, St James\u2019s University Hospital, Leeds, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Zieniewicz","sequence":"additional","affiliation":[{"name":"Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. E.","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herold J.","family":"Metselaar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Adam","sequence":"additional","affiliation":[{"name":"Hepato-Biliary Center, AP-HP Paul Brousse Hospital, University of Paris-Sud, INSERM U935, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Karam","sequence":"additional","affiliation":[{"name":"ELTR, H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Aguilera","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Transplant Unit, La Fe University Hospital and Ciberehd, IISLaFe, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00281-018-0715-8","article-title":"Sex-related factors in autoimmune liver diseases.","volume":"41","author":"Schwinge","year":"2019","journal-title":"Semin Immunopathol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2014a comprehensive review.","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications.","volume":"14","author":"Jiang","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J Hepatol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.cgh.2018.04.047","article-title":"Characteristics and outcomes reported by patients with primary sclerosing cholangitis through an online registry.","volume":"17","author":"Kuo","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis.","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1007\/s10620-017-4559-1","article-title":"Differences in phenotypes and liver transplantation outcomes by age group in patients with primary sclerosing cholangitis.","volume":"62","author":"Henson","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol"},{"issue":"suppl 2","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transpl"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transplant"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2050640617717156","article-title":"Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.","volume":"6","author":"Rupp","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","article-title":"Gender bias in autoimmunity is influenced by microbiota.","volume":"39","author":"Yurkovetskiy","year":"2013","journal-title":"Immunity"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.","volume":"66","author":"R\u00fchlemann","year":"2017","journal-title":"Gut"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0000000000001008","article-title":"The intestinal microbiome and the liver transplant recipient: what we know and what we need to know.","volume":"100","author":"Doycheva","year":"2016","journal-title":"Transplantation"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial.","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:13:02Z","timestamp":1749312782000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003542","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}